Left ventricular reverse remodeling after transcatheter aortic valve implantation: A cardiovascular magnetic resonance study

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  La Manna, Alessio ^a   Sanfilippo, Alessandra ^a   Capodanno, Davide ^a,b   Salemi, Antonella ^a   Cadoni, Alessandra ^a   Cascone, Irene ^a   Polizzi, Gesualdo ^c   Figuera, Michele ^c   Pittalà, Rosetta ^c   Privitera, Carmelo ^c   Tamburino, Corrado ^a,b  

^a Ferrarotto Hospital   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cardiovascular magnetic resonance; Transcatheter aortic valve implantation; Ventricular remodeling

Indexed keywords

GADOBUTROL;

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; BODY SURFACE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SURGICAL PATIENT; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; AORTIC VALVE STENOSIS; BIOPROSTHESIS; COMPLICATION; DEVICES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VENTRICLE; HEART VENTRICLE REMODELING; HYPERTROPHY, LEFT VENTRICULAR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84877885217     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-39     Document Type: Article

References (40)

1. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Lorell BH, Carabello BA, Circ 2000 102 4 470 479 10.1161/01.CIR.102.4.470 (Pubitemid 30490688)
2. Aortic stenosis. Otto CM, Bonow RO, Braunwald's heart disease Philadelphia: WB Saunders, Libby P, Bonow RO, Mann DL, Zipes DP, 8 2008 1626 1628 23698201
3. Aorticstenosis. Carabello BA, Paulus WJ, Lancet 2009 373 956 966 10.1016/S0140-6736(09)60211-7 19232707
4. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD, Circulation 2003 107 1884 1890 10.1161/01.CIR.0000060533.79248.0C 12668523 (Pubitemid 36444129)
5. Valvular aortic stenosis: disease severity and timing of intervention. Otto CM, J Am CollCardiol 2006 47 2141 2151 10.1016/j.jacc.2006.03.002 (Pubitemid 43795057)
6. Outcome and saphety of percutaneous valve replacement. Zajarias A, Cribier AG, J Am CollCardiol 2009 53 1829 1836 10.1016/j.jacc.2008.11.059
7. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. Leon MB, Smith CR, Miller DC MM, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, N Engl J Med 2010 363 1597 1607 10.1056/NEJMoa1008232 20961243
8. Incidence and predictors of early and late mortality after transcatheter AorticValve implantation in 663 patients with severe aortic stenosis. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP, Circulation 2011 123 299 308 10.1161/CIRCULATIONAHA.110. 946533 21220731
9. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, J Am Coll Cardiol 2012 59 13 1200 1254 10.1016/j.jacc.2012.01.001 22300974
10. Two-year outcomes after transcatheter or surgical aortic-valve replacement. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators, N Engl J Med 2012 366 18 1686 1695 10.1056/NEJMoa1200384 22443479
11. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB, J Am CollCardiol 2004 43 698 703 10.1016/j.jacc.2003.11.026 (Pubitemid 38229547)
12. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R, J Am CollCardiol 2007 50 69 76 10.1016/j.jacc.2007.04.047 (Pubitemid 46970878)
13. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. Ussia GP, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto AM, Immè S, Capodanno D, Sarkar K, Gulino S, Tamburino C, EuroIntervention 2011 7 5 573 579 10.4244/EIJV7I5A93 21930461
14. Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. Sherif MA, Abdel-Wahab M, Awad O, Geist V, El-Shahed G, Semmler R, Tawfik M, Khattab AA, Richardt D, Richardt G, Tölg R, Am Heart J 2010 160 5 862 869 10.1016/j.ahj.2010.07.017 21095273
15. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A, Am Heart J 2010 159 5 926 932 10.1016/j.ahj.2010.02.030 20435207
16. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 1 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
17. Magnetic resonance imaging safety: implications for cardiovascular patients. Ahmed S, Shellock FG, J Cardiovasc Magn Reson Imaging 2001 3 171 182 10.1081/JCMR-100107466 (Pubitemid 33062623)
18. C ardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, Cincotta G, Cadoni A, Marchese A, Figuera M, Ussia GP, Pittalà R, Privitera C, Tamburino C, J Cardiovasc Magn Reson 2011 13 82 10.1186/1532-429X-13-82 22202669
19. Normalized left ventricularsystolic and diastolic function by steady state free precession cardiovascularmagnetic resonance. Maceira AM, Prasad SK, Khan M, Pennell DJ, J Cardiovasc Magn Reson 2006 8 3 417 426 10.1080/10976640600572889 16755827
20. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. Rathod RH, Prakash A, Powell AJ, Geva T, J Am CollCardiol 2010 55 1721 1728 10.1016/j.jacc.2009.12.036
21. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Weidemann F, Herrmann S, Störk S, Niemann M, Frantz S, Lange V, Beer M, Gattenlöhner S, Voelker W, Ertl G, Strotmann JM, Circulation 2009 120 577 584 10.1161/CIRCULATIONAHA.108.847772 19652094
22. Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function. Ikonomidis I, Tsoukas A, Parthenakis F, Gournizakis A, Kassimatis A, Rallidis L, Nihoyannopoulos P, Heart 2001 86 309 316 10.1136/heart.86.3.309 11514485 (Pubitemid 32800082)
23. Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Walther T, Falk V, Langebartels G, Krüger M, Bernhardt U, Diegeler A, Gummert J, Autschbach R, Mohr FW, Circulation 1999 100 19 Suppl I6 II10 10567271
24. LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. Biederman RWW, Magovern JA, Grant BS, Williams RB, Yamrozik JA, Vido DA, Rathi VK, Rayarao G, Caruppannan K, Doyle M, J Cardiothorac Surg 2011 6 53 10.1186/1749-8090-6-53 21492429
25. Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE, J Am Coll Cardiol. 2002 40 12 2182 88 10.1016/S0735-1097(02)02604-9 12505232 (Pubitemid 36005906)
26. Left and right ventricular function in aortic stenosis patients 8 weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement. Forsberg LM, Tamás E, Vánky F, Nielsen NE, Engvall J, Nylander E, Eur J Echocardiogr. 2011 12 8 603 11 10.1093/ejechocard/jer085 21705353
27. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A, Am Heart J. 2010 May 159 5 926 32 10.1016/j.ahj.2010. 02.030
28. Acute improvement in arterial-ventricular coupling after transcatheter aortic valve implantation (CoreValve) in patients with symptomatic aortic stenosis. Di Bello V, Giannini C, De Carlo M, Delle Donne MG, Nardi C, Palagi C, Cucco C, Dini FL, Guarracino F, Marzilli M, Petronio AS, Int J Cardiovasc Imaging. 2012 28 1 79 87 10.1007/s10554-010-9772-3 21222040
29. Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study. Giannini C, Petronio AS, Talini E, De Carlo M, Guarracino F, Grazia M, Donne D, Nardi C, Conte L, Barletta V, Marzilli M, Di Bello V, Am J Cardiovasc Dis. 2011 1 3 264 73 22254204
30. Left ventricular mass regression one year after transcatheter aortic valve implantation. Tzikas A, Geleijnse ML, Van Mieghem NM, Schultz CJ, Nuis RJ, van Dalen BM, Sarno G, van Domburg RT, Serruys PW, de Jaegere PP, Ann Thorac Surg. 2011 91 3 685 91 10.1016/j.athoracsur.2010.09.037 21352980
31. Relative importance of errors in left ventricular quantitation by two-dimensional echocardiography: insights from three-dimensional echocardiography and cardiac magnetic resonance imaging. Chukwu EO, Barasch E, Mihalatos DG, Katz A, Lachmann J, Han J, Reichek N, Gopal AS, Am Soc Echocardiogr. 2008 21 990 97 10.1016/j.echo.2008.07.009
32. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH, J Am CollCardiol. 2011 58 21 2165 73 10.1016/j.jacc.2011.09.010
33. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. Sherif MA, Abdel-Wahab M, Beurich HW, Stöcker B, Zachow D, Geist V, Tölg R, Richardt G, EuroIntervention. 2011 7 1 57 63 10.4244/EIJV7I8A12 21550904
34. A meta-analysis and investigation for the source of bias of left ventricular volumes and function by three-dimensional echocardiography in comparison with magnetic resonance imaging. Shimada YJ, Shiota T, Am J Cardiol. 2011 107 126 38 10.1016/j.amjcard.2010.08.058 21146700
35. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V, J Am Coll Cardiol. 2006 47 6 1214 23 10.1016/j.jacc.2006.01.049 16545654
36. Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcome. Bové T, Van Belleghem Y, François K, Caes F, Van Overbeke H, Van Nooten G, Eur J CardiothoracSurg. 2006 30 5 706 13 10.1016/j.ejcts.2006.07.017 (Pubitemid 44572760)
37. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Lefèvre T, J Am CollCardiol. 2012 59 6 566 71 10.1016/j.jacc.2011.10.877
38. Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galiñanes M, Am Heart J. 2003 146 4 13 10.1016/j.ahj.2003.09.004 14564336 (Pubitemid 37268203)
39. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC, EurHeart J Cardiovasc Imaging. 2012 13 10 819 26
40. Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. Steadman CD, Jerosch-Herold M, Grundy B, Rafelt S, Ng LL, Squire IB, Samani NJ, McCann GP, JACC Cardiovasc Imaging. 2012 5 2 182 89 10.1016/j.jcmg.2011.09.022 22340825